Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

OptiBiotix brings on board experienced sales director

Christina Wood will join the board in due course subject to the necessary due diligence

Life sciences group OptiBiotix Health plc (LON:OPTI) is bringing on board an experienced sales and marketing director to help create new revenue streams for OptiBiotix’s pipeline of products.

Christina Wood will join the team in due course subject to the completion of the normal regulatory due diligence, Opti said.

She has been brought in to help take OptiBiotix’s products, including its patented SlimBiome weight loss products, into overseas markets.

Wood has more than 20 years’ sales experience in the food, nutrition and nutraceuticals industry and has struck deals with likes of Nestlé, Danone and Heinz in the past in her role as chief executive and owner of ingredients supplier Confoco.

Most recently, she was the director of sales and marketing at UK food supplier John Morley where she was responsible for key accounts including Tesco PLC (LON:TSCO) and J Sainsbury plc (LON:SBRY).

“Christina's experience of building sales in her own business by developing relationships with food ingredient manufacturers and major retailers brings new elements of operational, commercial and industry expertise to OptiBiotix,” said chief executive Stephen O’Hara in this morning’s statement.

Speaking exclusively to Proactive, he added: “You can see we’re transitioning now from a company that was very much focused on developing products to a company that is now commercialising their products.”

Shares were up 5.5%, or 3.8p, to 72.3p.

-- Updates for share price and additional CEO comment --

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK